|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Departments of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tenn.
2 From the Department Cardiothoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Study objective: The purpose of this study was to evaluate the accuracy of positron emission tomography (PET) using F-18-fluorodeoxyglucose (FDG) in differentiating benign from malignant pulmonary lesions both in patients with and without a history of prior malignancy.
Design: Forty-eight consecutive patients with pulmonary lesions suspicious for malignancy underwent FDG-PET scanning. Group 1 included 27 patients without and group 2 included 21 patients with a history of malignancy. Pathologic proof of diagnosis was obtained for 32 patients and 16 patients were followed up clinically and radiographically for at least 6 months. The standard uptake ratio (SUR) and the lesion to background (L/B) ratio were determined in 45 patients.
Setting: Vanderbilt University Medical Center.
Results: In group 1, the average SUR and L/B ratio for malignant lesions (n=14) were 8.9±4.9 and 20.6±14.2, respectively. For benign lesions (n=12), the average SUR was 3.3±3.2 and L/B ratio was 5.2±5.5. In group 2, the average SUR and L/B ratio for malignant lesions were not significantly different from group 1. Using either a SUR greater than 2.5 or L/B ratio greater than 5 as an cutoff level to differentiate benign and malignant lesions, the sensitivity and negative predictive value in both groups were 100%. There were five false-positive studies in group 1 and one in group 2, including tuberculosis (n=2), a granulomatous lesion (n=1), an inflammatory lesion (n=1), a schwannoma (n=1), and a fibrous mesothelioma (n=1). The overall accuracy was 88%, 81% in group 1, and 95% in group 2.
Conclusion: FDG-PET can identify malignant pulmonary lesions both in patients without and with a history of prior malignancy with a high sensitivity and negative predictive value for lesions greater than 1 cm (100% in this study). High FDG uptake by some inflammatory processes and benign tumors may cause false-positive results. Semiquantitative evaluation using SUR or L/B ratio provides similar accuracy.
Key Words: emission CT fluorine glucose metabolism lung neoplasms
Submitted on July 6, 1995
Accepted on November 15, 2007
This article has been cited by other articles:
![]() |
S. S. Shim, K. S. Lee, B.-T. Kim, J. Y. Choi, M. J. Chung, and E. J. Lee Focal Parenchymal Lung Lesions Showing a Potential of False-Positive and False-Negative Interpretations on Integrated PET/CT. Am. J. Roentgenol., March 1, 2006; 186(3): 639 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Younes-Mhenni, M. F. Janier, L. Cinotti, J. C. Antoine, F. Tronc, V. Cottin, P. J. Ternamian, P. Trouillas, and J. Honnorat FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes Brain, October 1, 2004; 127(10): 2331 - 2338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Beaulieu, B. Rubin, D. Djang, E. Conrad, E. Turcotte, and J. F. Eary Positron Emission Tomography of Schwannomas: Emphasizing Its Potential in Preoperative Planning Am. J. Roentgenol., April 1, 2004; 182(4): 971 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Dagher, T. Bartter, W. S. Kfoury, Z. C. Boujaoude, and M. R. Pratter Pulmonary Cryptococcoma Mimicking Malignancy in a Normal Host Chest Meeting Abstracts, October 1, 2003; 124(4): 326S - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hara, N. Kosaka, T. Suzuki, K. Kudo, and H. Niino Uptake Rates of 18F-Fluorodeoxyglucose and 11C-Choline in Lung Cancer and Pulmonary Tuberculosis: A Positron Emission Tomography Study Chest, September 1, 2003; 124(3): 893 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fritscher-Ravens, K. H. Bohuslavizki, L. Brandt, C. Bobrowski, C. Lund, W. T. Knofel, and A. Pforte Mediastinal Lymph Node Involvement in Potentially Resectable Lung Cancer: Comparison of CT, Positron Emission Tomography, and Endoscopic Ultrasonography With and Without Fine-Needle Aspiration Chest, February 1, 2003; 123(2): 442 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rivera, F. Detterbeck, and A. C. Mehta Diagnosis of Lung Cancer: The Guidelines Chest, January 1, 2003; 123(1_suppl): 129S - 136S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matthies, M. Hickeson, A. Cuchiara, and A. Alavi Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules J. Nucl. Med., July 1, 2002; 43(7): 871 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fenchel, D. Grab, K. Nuessle, J. Kotzerke, A. Rieber, R. Kreienberg, H.-J. Brambs, and S. N. Reske Asymptomatic Adnexal Masses: Correlation of FDG PET and Histopathologic Findings Radiology, June 1, 2002; 223(3): 780 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, J. M. Aronchick, and A. Alavi Accuracy of F-18 Fluorodeoxyglucose Positron Emission Tomography for the Evaluation of Malignancy in Patients Presenting With New Lung Abnormalities : A Retrospective Review Chest, December 1, 2001; 120(6): 1791 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps A Tabulated Summary of the FDG PET Literature J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93. [Full Text] [PDF] |
||||
![]() |
H.-P. Hauber, K. H. Bohuslavizki, C. H. Lund, A. Fritscher-Ravens, A. Meyer, and A. Pforte Positron Emission Tomography in the Staging of Small-Cell Lung Cancer : A Preliminary Study Chest, March 1, 2001; 119(3): 950 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Reinhardt, C. Ehritt-Braun, D. Vogelgesang, C. Ihling, S. Högerle, M. Mix, E. Moser, and T. M. Krause Metastatic Lymph Nodes in Patients with Cervical Cancer: Detection with MR Imaging and FDG PET Radiology, March 1, 2001; 218(3): 776 - 782. [Abstract] [Full Text] |
||||
![]() |
M. K. Gould, C. C. Maclean, W. G. Kuschner, C. E. Rydzak, and D. K. Owens Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass Lesions: A Meta-analysis JAMA, February 21, 2001; 285(7): 914 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-U. Hung, Y.-C. Shiau, S.-C. Tsai, Y.-J. Ho, C.-H. Kao, and R.-F. Yen Differentiation of Radiographically Indeterminate Solitary Pulmonary Nodules with [18F]Fluoro-2-deoxyglucose Positron Emission Tomography Jpn. J. Clin. Oncol., February 1, 2001; 31(2): 51 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. McCain, D. P. Dunagan, R. Chin Jr., T. Oaks, B. A. Harkness, and E. F. Haponik The Usefulness of Positron Emission Tomography in Evaluating Patients for Pulmonary Malignancies Chest, December 1, 2000; 118(6): 1610 - 1615. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Goo, J.-G. Im, K.-H. Do, J. S. Yeo, J. B. Seo, H. Y. Kim, and J.-K. Chung Pulmonary Tuberculoma Evaluated by Means of FDG PET: Findings in 10 Cases Radiology, July 1, 2000; 216(1): 117 - 121. [Abstract] [Full Text] |
||||
![]() |
E. F. Patz Jr 1999 Plenary Session: Friday Imaging Symposium : Evaluation of Focal Pulmonary Abnormalities with FDG PET RadioGraphics, July 1, 2000; 20(4): 1182 - 1185. [Full Text] [PDF] |
||||
![]() |
J. Blum, H. Handmaker, J. Lister-James, and N. Rinne A Multicenter Trial With a Somatostatin Analog 99mTc Depreotide in the Evaluation of Solitary Pulmonary Nodules Chest, May 1, 2000; 117(5): 1232 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Patz Jr., J. Connolly, and J. Herndon Prognostic Value of Thoracic FDG PET Imaging After Treatment for Non-Small Cell Lung Cancer Am. J. Roentgenol., March 1, 2000; 174(3): 769 - 774. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Coleman, C. M. Laymon, and T. G. Turkington FDG Imaging of Lung Nodules: A Phantom Study Comparing SPECT, Camera-based PET, and Dedicated PET Radiology, March 1, 1999; 210(3): 823 - 828. [Abstract] [Full Text] |
||||
![]() |
P. G. Rose, L. P. Adler, M. Rodriguez, P. F. Faulhaber, F. W. Abdul-Karim, and F. Miraldi Positron Emission Tomography for Evaluating Para-aortic Nodal Metastasis in Locally Advanced Cervical Cancer Before Surgical Staging: A Surgicopathologic Study J. Clin. Oncol., January 1, 1999; 17(1): 41 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J Lowe and K. S Naunheim Current role of positron emission tomography in thoracic oncology Thorax, August 1, 1998; 53(8): 703 - 712. [Full Text] |
||||
![]() |
V. J. Lowe and K. S. Naunheim Positron Emission Tomography in Lung Cancer Ann. Thorac. Surg., June 1, 1998; 65(6): 1821 - 1829. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |